Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2026-06-16 @ 7:42 PM
Study NCT ID:
NCT02153905
Status:
TERMINATED
Last Update Posted:
2019-06-17
First Post:
2014-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-03
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-31
First Submit QC Date:
None
Study First Post Date:
2014-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-10
Results First Submit QC Date:
None
Results First Post Date:
2019-06-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-04
Last Update Post Date:
2019-06-17
Last Update Post Date Type:
ACTUAL